Mobidiag to Offer Amplidiag® Diagnostics Products in South Africa

Mobidiag to Offer Amplidiag® Diagnostics Products in South Africa

Diagnostics

Mobidiag to Offer Amplidiag® Diagnostics Products in South Africa

ESPOO, Finland, January 17th, 2017 – Mobidiag Ltd, a Finnish molecular diagnostics company, today announced that it will offer the Amplidiag® product line in South Africa through a distribution agreement with PerkinElmer® Inc.’s Wallac Oy subsidiary. The Amplidiag® product line includes in vitro diagnostic tests and compatible systems for the detection of gastrointestinal infections.

“Thanks to a large distribution network, our Amplidiag product line is now accessible in most European countries. Our ambition is now to expand our coverage worldwide and towards new markets, starting with Africa. In order to develop ourselves in this specific market, we were looking for a distributor with acknowledged expertise and worldwide leadership in the field of diagnostics. We are then very happy that PerkinElmer agreed to accompany us in this great endeavor,” said Tuomas Tenkanen, CEO at Mobidiag.

“PerkinElmer continues to expand our infectious disease offerings in regions such as Africa to help meet the health needs of these populations,” said Hanna Halme, PerkinElmer’s Vice-President for EMEA.

The agreement is effective immediately and covers all Amplidiag® IVD tests (Amplidiag® H.pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and upcoming Amplidiag® Viral GE) as well as the Amplidiag® Easy system.

Contact
Tuomas Tenkanen
+358 505534980
tuomas.tenkanen(a)mobidiag.com


Related posts